Ubs Group Ag Cytosorbents Corp Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Cytosorbents Corp stock. As of the latest transaction made, Ubs Group Ag holds 2,571 shares of CTSO stock, worth $2,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,571

Previous 1,857 38.45%

Holding current value

$2,416

Previous $1,000 200.0%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.55 $499 - $1,106	714 Added 38.45%	2,571 $3,000
Q2 2024 Aug 13, 2024	BUY	$0.7 - $1.01 $1,260 - $1,818	1,800 Added 3157.89%	1,857 $1,000
Q1 2024 May 13, 2024	SELL	$0.86 - $1.07 $2,497 - $3,107	-2,904 Reduced 98.07%	57 $0
Q4 2023 Feb 09, 2024	BUY	$1.08 - $1.94 $2,985 - $5,362	2,764 Added 1403.05%	2,961 $3,000
Q3 2023 Nov 09, 2023	SELL	$1.86 - $4.03 $1,726 - $3,739	-928 Reduced 82.49%	197 $0
Q2 2023 Aug 11, 2023	BUY	$2.37 - $3.65 $1,528 - $2,354	645 Added 134.38%	1,125 $4,000
Q1 2023 May 12, 2023	SELL	$1.79 - $4.17 $5,488 - $12,785	-3,066 Reduced 86.46%	480 $1,000
Q4 2022 Feb 08, 2023	SELL	$1.03 - $2.03 $2,175 - $4,287	-2,112 Reduced 37.33%	3,546 $5,000
Q3 2022 Nov 10, 2022	BUY	$1.2 - $2.46 $6,240 - $12,792	5,200 Added 1135.37%	5,658 $7,000
Q2 2022 Aug 10, 2022	SELL	$1.76 - $3.22 $4,813 - $8,806	-2,735 Reduced 85.66%	458 $1,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $23,212 - $34,093	-8,060 Reduced 71.63%	3,193 $10,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $39,098 - $78,293	9,654 Added 603.75%	11,253 $48,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $12,733 - $17,662	-1,819 Reduced 53.22%	1,599 $13,000
Q2 2021 Aug 13, 2021	SELL	$7.55 - $9.42 $31,438 - $39,224	-4,164 Reduced 54.92%	3,418 $26,000
Q1 2021 May 12, 2021	SELL	$8.23 - $11.48 $1,983 - $2,766	-241 Reduced 3.08%	7,582 $66,000
Q4 2020 Feb 11, 2021	BUY	$7.65 - $8.98 $57,505 - $67,502	7,517 Added 2456.54%	7,823 $62,000
Q3 2020 Nov 12, 2020	SELL	$7.37 - $11.54 $97,107 - $152,051	-13,176 Reduced 97.73%	306 $2,000
Q2 2020 Jul 31, 2020	SELL	$6.28 - $10.59 $95,261 - $160,639	-15,169 Reduced 52.94%	13,482 $133,000
Q1 2020 May 01, 2020	SELL	$3.77 - $7.73 $54,152 - $111,033	-14,364 Reduced 33.39%	28,651 $221,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $66,156 - $95,661	18,326 Added 74.23%	43,015 $166,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $7.63 $99,719 - $175,718	-23,030 Reduced 48.26%	24,689 $124,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.78 $74,467 - $97,864	12,579 Added 35.8%	47,719 $315,000
Q1 2019 May 14, 2019	BUY	$6.82 - $8.56 $26,645 - $33,443	3,907 Added 12.51%	35,140 $266,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $57,161 - $102,485	8,108 Added 35.06%	31,233 $253,000
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $135,626 - $183,312	-12,386 Reduced 34.88%	23,125 $299,000
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $244,363 - $437,375	35,415 Added 36890.63%	35,511 $405,000
Q1 2018 May 15, 2018	SELL	$6.55 - $8.2 $9,163 - $11,471	-1,399 Reduced 93.58%	96 $1,000
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $8,820 - $10,539	1,495 New	1,495 $10,000
Q2 2017 Aug 14, 2017	SELL	N/A	-94 Closed	0 $0
Q1 2017 Nov 14, 2017	BUY	N/A	94	94 $0

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.7M

Call Options Held

15.4K

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $41M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account